Transcription

• Speaker #0

  the generation of pathologists guiding a changing field. Nominations open for the 2026 Meritorious Service Awards and Why Blood Counts Matter During Chemotherapy, coming up next. This is the Path News Network Daily Edition, powered by the College of American Pathologists. I'm Stevan Borel. It's Thursday, January 22nd, and here are the latest headlines. Pathology is navigating a major transition, and zineopathologists are helping guide the shift. This is the age group born after Generation X and before Millennials. Trained on microscopes and glass slides, zineals learn diagnosis through slow, deliberate visual judgment. Today, they're also helping integrate digital pathology and computational tools into daily practice. Dr. Cameron Mirza, Chair of the CAP, and Hematopthalogy Committee says in a recent article in The Pathologist that the moment requires balance. Quote, the technology is evolving, but careful interpretation and clinical judgment still define our work. As pathology moves forward, zineopathologists help connect tradition with innovation, keeping patient care at the center. In other news. The CAP is now accepting nominations for its 2026 Meritorious Service Awards program. The program recognizes CAP members for outstanding contributions to pathology, laboratory medicine, patient care, public service, and the CAP. Award recipients are invited to accept their honors in person at the CAP annual meeting. Nominations are open now through March 16th. Current CAP officers, board members, and candidates for elected office are now eligible. Self-nominations and incomplete submissions will not be considered. Award recommendations are reviewed by CAP councils and the Member Engagement Committee with final approval by the Board of Governors in May. If you or someone you love is undergoing chemotherapy, The frequent blood tests can feel exhausting, but they're a critical part of staying safe. In a recent article by Patient Power, CAP experts explain why blood counts are closely monitored during treatment. Dr. Megino Nakashima, chair of the CAP Hematopthalogy Committee, says chemotherapy targets fast-growing cells, including healthy blood cells. Blood counts are monitored during chemotherapy because chemotherapy can affect the blood counts and because the counts indicate how well your body can handle the treatment. Dr. Elizabeth Margolsky, a member of the CAP Hematopthalogy Committee, adds that drops in neutrophils, platelets, and hemoglobin help guide decisions about infection risk, transfusions, and treatment timing. These blood tests allow care teams to adjust treatment in real time. Protecting patients throughout the chemotherapy. And finally, a commitment to quality and patient safety is being recognized in Kentucky. Harrison Memorial Hospital's laboratory has earned reaccreditation from the CAP following a recent on-site inspection. The laboratory has maintained CAP accreditation since 2006. During their review, inspectors examined two years of records, quality control results, staff qualifications, equipment, and management practices. HMH Chief Executive Officer Dr. Kathy Tussey says their recognition reflects the team's dedication. This reaccreditation affirms the strength, consistency, and dedication of our laboratory team. That's all we have for today. Check out the show notes for topics covered. You can find us on Apple Podcasts, Amazon Music, or Spotify. Subscribe on your favorite platform. Look for more news like this in our weekly newsletters published every Tuesday and Thursday. We'll be back tomorrow at 5 a.m. Eastern with more CAP News. For The Daily Edition, I'm Stevon Burrel. Have a great day.